OSI-906 (Linsitinib) | CAS 867160-71-2 | AbMole BioScience | OSI-906 Price
Linsitinib (OSI-906) modulates brain energy metabolism and seizure activity in the lithium-pilocarpine rat model | Acta Epileptologica | Full Text
Insulin-IGF signaling affects cell transformation in the BALB/c 3T3 cell model | Scientific Reports
Metabolic recovery of lipodystrophy, liver steatosis, and pancreatic β cell proliferation after the withdrawal of OSI-906 | Scientific Reports
Linsitinib (OSI-906) modulates brain energy metabolism and seizure activity in the lithium-pilocarpine rat model | Acta Epileptologica | Full Text
Linsitinib (OSI-906) | ≥99%(HPLC) | Selleck | IGF-1R 阻害剤
Linsitinib (OSI-906) | IGF-1R/Insulin Receptor Inhibitor | MedChemExpress
IJMS | Free Full-Text | Combination Treatment of OSI-906 with Aurora B Inhibitor Reduces Cell Viability via Cyclin B1 Degradation-Induced Mitotic Slippage
OSI-906 restores the sensitivity of ovarian clear cell carcinoma to cisplatin by targeting the IGF1R/AKT pathway | Medical Oncology
Linsitinib (OSI-906) (CAS 867160-71-2) (ab273391) | Abcam
a, b: Effect of linsitinib (OSI-906 indicated as Osi), alone or in... | Download Scientific Diagram
Linsitinib (OSI-906) | IGF-1R/Insulin Receptor Inhibitor | MedChemExpress
IJMS | Free Full-Text | Combination Treatment of OSI-906 with Aurora B Inhibitor Reduces Cell Viability via Cyclin B1 Degradation-Induced Mitotic Slippage
Linsitinib (OSI-906) | ≥99%(HPLC) | Selleck | IGF-1R 阻害剤
Linsitinib (OSI-906) | IGF-1R/Insulin Receptor Inhibitor | MedChemExpress
Cancers | Free Full-Text | Differential Effects of IGF-1R Small Molecule Tyrosine Kinase Inhibitors BMS-754807 and OSI-906 on Human Cancer Cell Lines
OSI-906_Biotool LLC
OSI-906
OSI-906
![PDF] Epithelial–Mesenchymal Transition Predicts Sensitivity to the Dual IGF-1R/IR Inhibitor OSI-906 in Hepatocellular Carcinoma Cell Lines | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c23f93ae50953af4c9f19e953bd7d256df2aa24f/4-Figure1-1.png "PDF] Epithelial–Mesenchymal Transition Predicts Sensitivity to the Dual IGF-1R/IR Inhibitor OSI-906 in Hepatocellular Carcinoma Cell Lines | Semantic Scholar")
PDF] Epithelial–Mesenchymal Transition Predicts Sensitivity to the Dual IGF-1R/IR Inhibitor OSI-906 in Hepatocellular Carcinoma Cell Lines | Semantic Scholar
Inhibition of the IR-IGF-1R axis by OSI-906 affects several downstream... | Download Scientific Diagram
Luseogliflozin increases beta cell proliferation through humoral factors that activate an insulin receptor- and IGF-1 receptor-independent pathway | Diabetologia
